Track the 제이에스링크 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 제이에스링크 has published 83 public disclosures. Market capitalisation: €967.7bn. The latest transaction was reported on 22 April 2026 (Purchase). Among the most active insiders: 주성씨앤에어. The full history is free.
83
Insider Decl.
n/a
Thresholds
n/a
50 ops.
Buy Volume
n/a
2 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,950 of 28,169 companies
19.5
score / 100
Value
27
Quality
12
FCF yld-4.0%
Earn yld-1.2%
EV/EBITDA·
ROE-26%
Gross mgn19%
Net mgn-85%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
제이에스링크 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of pharmaceutical products.